D-0333-2021 Class II Terminated
FDA drug recall D-0333-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Apr 1, 2021 and is designated Class II. Reason for recall: Failed Dissolution Specifications The recall status is terminated (terminated Apr 28, 2022). Affected quantity: Lot #IT119008B - (4,128 Bottles); Lot #IT20001A - (3,984 Bottles); Lot #IT20002B - (4.080 Bottles).
Recall details
- Product Type
- Drugs
- Report Date
- Apr 21, 2021
- Initiation Date
- Apr 1, 2021
- Termination Date
- Apr 28, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- Lot #IT119008B - (4,128 Bottles); Lot #IT20001A - (3,984 Bottles); Lot #IT20002B - (4.080 Bottles)
Product description
Itraconazole Capsules, 100 mg, 30-count bottles, Rx only, Manufactured by: Jubilant Generics Ltd., Roorkee - 247661, India; Marketed by: Jubilant Cadista Pharmaceuticals, Inc., Salisbury, MD 21801, NDC 59746-282-30.
Reason for recall
Failed Dissolution Specifications
Distribution pattern
Nationwide in the USA
Code information
Lot #s: IT119008B, Exp 05/2021; IT120001A, IT120002A, Exp 12/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0333-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026